FDP
AUPH icon

Financiere des Professionnels’s Aurinia Pharmaceuticals AUPH Stock Holding History

Financiere des Professionnels’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Hold
26,717
– – 0.03% 246
2026
Q1 		$396K Buy
26,717
+8,784
+49% +$128K 0.02% 250
2025
Q4 		$286K Buy
+17,933
New +$254K 0.02% 257

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financiere des Professionnels's AUPH Position: Q2 2026 in Review

Financiere des Professionnels held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 26,717 shares worth $453K. The position accounts for 0.03% of the portfolio, ranked #246.

Financiere des Professionnels first reported a position in AUPH in Q4 2025 and has held it in 3 quarters since. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Financiere des Professionnels held 26,717 shares of Aurinia Pharmaceuticals worth $453K as of Q2 2026.
  • Financiere des Professionnels left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.03% of Financiere des Professionnels's portfolio in Q2 2026, its #246 holding.
  • Financiere des Professionnels first reported a position in Aurinia Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.